The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
Open accessAbstract
Pooled data on human papillomavirus (HPV) type distribution in invasive cervical cancer (ICC) can help to predict the potential impact of HPV type‐specific vaccines and screening tests, and to understand the carcinogenicity of HPV types. We performed a meta‐analysis of HPV type‐specific prevalence data published from 1990 to 2010, including a total of 243 studies and 30,848 ICC. The proportion of ICC associated with HPV16 and/or 18 (HPV16/18) was between 70 and 76% in all world regions except Asia. In Western/Central Asia, 82% of ICC was HPV16/18‐associated compared to only 68% in Eastern Asia. The 12 most common HPV types identified, in order of decreasing prevalence, were HPV16 (57%), 18 (16%), 58, 33, 45, 31, 52, 35, 59, 39, 51 and 56. The prevalence of other types, phylogenetically related to those above, ranged from <0.1% for HPV85 to 0.6% for HPV68. Overall HPV prevalence increased significantly from 85.9% in studies published from 1990 to 1999 to 92.9% in studies published from 2006 to 2010. Prevalence increases were large for multiple infections (from 4.0 to 15.7%) and for HPV16 (from 51.8 to 60.0%, including HPV16 alone or in multiple infections). Smaller but significant increases in prevalence were also seen for HPV39, 53 and 58. A large amount of recently published data has improved the understanding of the contribution of a broad range of HPV types to ICC in different world regions. However, estimating the fraction of ICC attributable to different types is increasingly complicated by the detection of multiple HPV infections in ICC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Self-citationHuman papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Self-citationMuñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Clifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
Self-citationSchiffman, M., Clifford, G., & Buonaguro, F. M. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 448
Self-citationThe carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Snijders, P. J., van den Brule, A. J., & Meijer, C. J. (2003) · The Journal of Pathology · doi:10.1002/path.1433 · Cited by 278
Self-citationWentzensen, N., Schiffman, M., Dunn, T., Zuna, R. E., Gold, M. A., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S., Walker, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24528 · Cited by 185
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Self-citationGuan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Human papillomavirus and cervical cancer
Okunade, K. S. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1634030 · Cited by 809
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv086 · Cited by 761
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjosé, S., & Trottier, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70471-1 · Cited by 722
Wheeler, C. M., Castellsagué, X., Garland, S. M., Szarewski, A., Paavonen, J., Naud, P., Salmerón, J., Chow, S.-N., Apter, D., Kitchener, H., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70287-x · Cited by 507
Huh, W. K., Ault, K. A., Chelmow, D., Davey, D. D., Goulart, R. A., Garcia, F. A. R., Kinney, W. K., Massad, L. S., Mayeaux, E. J., Saslow, D., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.022 · Cited by 489
Human papillomavirus genome variants
Burk, R. D., Harari, A., & Chen, Z. (2013) · Virology · doi:10.1016/j.virol.2013.07.018 · Cited by 484
The projected timeframe until cervical cancer elimination in Australia: a modelling study
Hall, M. T., Simms, K. T., Lew, J.-B., Smith, M. A., Brotherton, J. M., Saville, M., Frazer, I. H., & Canfell, K. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30183-x · Cited by 440
The human papillomavirus family and its role in carcinogenesis
Tommasino, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.002 · Cited by 411
Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H.-R., Pirog, E. C., Guimerà, N., Hernandez-Suarez, G., Felix, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.28963 · Cited by 388
Diseases associated with human papillomavirus infection
Cubie, H. A. (2013) · Virology · doi:10.1016/j.virol.2013.06.007 · Cited by 356
Egawa, N., & Doorbar, J. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.017 · Cited by 330
Human Papillomavirus Vaccines: An Updated Review
Cheng, L., Wang, Y., & Du, J. (2020) · Vaccines · doi:10.3390/vaccines8030391 · Cited by 329
Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01097-3 · Cited by 317
Self-citationPotential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Serrano, B., Alemany, L., Tous, S., Bruni, L., Clifford, G. M., Weiss, T., Bosch, F. X., & de Sanjosé, S. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-38 · Cited by 301
Self-citationHuh, W. K., Ault, K. A., Chelmow, D., Davey, D. D., Goulart, R. A., Garcia, F. A. R., Kinney, W. K., Massad, L. S., Mayeaux, E. J., Saslow, D., et al. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000669 · Cited by 280
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Gertig, D. M., Brotherton, J. M., Budd, A. C., Drennan, K., Chappell, G., & Saville, A. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-227 · Cited by 277
The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa
De Vuyst, H., Alemany, L., Lacey, C., Chibwesha, C. J., Sahasrabuddhe, V., Banura, C., Denny, L., & Parham, G. P. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.07.092 · Cited by 276
Key Molecular Events in Cervical Cancer Development
Balasubramaniam, S. D., Balakrishnan, V., Oon, C. E., & Kaur, G. (2019) · Medicina · doi:10.3390/medicina55070384 · Cited by 263
Jit, M., Brisson, M., Portnoy, A., & Hutubessy, R. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70237-2 · Cited by 261
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
VALGENT: a protocol for clinical validation of human papillomavirus assays
Arbyn, M., Depuydt, C., Benoy, I., Bogers, J., Cuschieri, K., Schmitt, M., Pawlita, M., Geraets, D., Heard, I., Gheit, T., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.09.014 · Cited by 157
Van de Velde, N., Boily, M.-C., Drolet, M., Franco, E. L., Mayrand, M.-H., Kliewer, E. V., Coutlée, F., Laprise, J.-F., Malagón, T., & Brisson, M. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs395 · Cited by 140
Campos, N. G., Sharma, M., Clark, A., Lee, K., Geng, F., Regan, C., Kim, J., & Resch, S. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12184 · Cited by 76
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
Riethmuller, D., Jacquard, A.-C., Lacau St Guily, J., Aubin, F., Carcopino, X., Pradat, P., Dahlab, A., & Prétet, J.-L. (2015) · BMC Public Health · doi:10.1186/s12889-015-1779-1 · Cited by 61
Paz-Zulueta, M., Álvarez-Paredes, L., Rodríguez Díaz, J. C., Parás-Bravo, P., Andrada Becerra, M. E., Rodríguez Ingelmo, J. M., Ruiz García, M. M., Portilla, J., & Santibañez, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4033-2 · Cited by 58
Brisson, M., Laprise, J.-F., Drolet, M., Van de Velde, N., Franco, E. L., Kliewer, E. V., Ogilvie, G., Deeks, S. L., & Boily, M.-C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.064 · Cited by 56
Park, Y., Lee, E., Choi, J., Jeong, S., & Kim, H.-S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00337-12 · Cited by 51
Bonde, J., Ejegod, D. M., Cuschieri, K., Dillner, J., Heideman, D. A. M., Quint, W., Pavon Ribas, M. A., Padalko, E., Christiansen, I. K., Xu, L., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.09.012 · Cited by 44
Martins, T. R., Mendes de Oliveira, C., Rosa, L. R., de Campos Centrone, C., Rodrigues, C. L. R., Villa, L. L., & Levi, J. E. (2016) · Virology Journal · doi:10.1186/s12985-016-0594-3 · Cited by 42
Baloch, Z., Li, Y., Yuan, T., Feng, Y., Liu, Y., Tai, W., Liu, L., Wang, B., Zhang, A.-M., Wu, X., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1562-7 · Cited by 42
Prevalence of human papillomavirus types in cervical lesions from women in rural Western India
Deodhar, K., Gheit, T., Vaccarella, S., Romao, C. C., Tenet, V., Nene, B. M., Jayant, K., Kelkar, R., Malvi, S. G., Sylla, B. S., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23310 · Cited by 34
Self-citationHuman Papillomavirus Genotype Distribution in Invasive Cervical Cancer in Pakistan
Loya, A., Serrano, B., Rasheed, F., Tous, S., Hassan, M., Clavero, O., Raza, M., De Sanjosé, S., Bosch, F., & Alemany, L. (2016) · Cancers · doi:10.3390/cancers8080072 · Cited by 27
Heydari, N., Oskouee, M. A., Vaezi, T., Shoja, Z., Esmaeili, H. A., Hamkar, R., Shahmahmoodi, S., & Jalilvand, S. (2018) · Journal of Medical Virology · doi:10.1002/jmv.24908 · Cited by 20
Chagas, B. S., Comar, M., Gurgel, A. P. A. D., Paiva, S., Seraceni, S., de Freitas, A. C., & Crovella, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132570 · Cited by 19
Prevalence of human papillomavirus 16 genotype in Anuppur district, Madhya Pradesh
Gupta, B., Sunnam, L. B., Kumar, A., & Parikipandla, S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06082-2 · Cited by 10
Malagón, T., & Franco, E. L. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwaa120 · Cited by 2
Metadata
- Authors
- Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-12-22
- Volume
- 128
- Issue
- 4
- Pages
- 927-935
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1964927845
- Cited by
- 1,066
- References
- 14
- FWCI
- 47.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.